catalyst · primary record
KPL-387 + Placebo
Phase readout · 2027-12-31 · Pericarditis, Pericarditis Acute, Recurrent Pericarditis
| Company | Kiniksa Pharmaceuticals International, plc |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | P2/P3 primary completion · NCT07010159 |
| Source | ClinicalTrials.gov |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:33.865Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: Kiniksa Pharmaceuticals International, plc:KPL-387 + Placebo:2027-12-31:P2/P3 primary completion · NCT07010159
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.